CD151 interacts with integrin beta 2 in B cell lymphomas.
Saved in:
| Title: | CD151 interacts with integrin beta 2 in B cell lymphomas. |
|---|---|
| Authors: | Hagemann PM; Department of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Kenyon AN; Department of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Cabrera-Orefice A; Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Arp AB; Department of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Hesius EAM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., van den Brand M; Pathology-DNA, Rijnstate Hospital, Arnhem, The Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van Deventer SJ; Department of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., de Jong D; Department of Pathology, Antoni Van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands., Scheijen B; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Xu-Monette ZY; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Brandt U; Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Spruijt CG; Department of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands., Vermeulen M; Department of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands.; Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Ter Beest M; Department of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Young KH; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., van Spriel AB; Department of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. annemiek.vanspriel@radboudumc.nl. |
| Source: | Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2025 Jun 04; Vol. 82 (1), pp. 221. Date of Electronic Publication: 2025 Jun 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
